Health

Jin Medical International Limited Receives NASDAQ Notification Letter Regarding Noncompliance with Continued Listing Rule 5550(a)(3)

CHANGZHOU, China, Sept. 28, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("JinMed" or "the Company") (NASDAQ: ZJYL), aCayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, received a written notification letter ("t...

2023-09-29 04:30 2094

AMRIC, A New Premium Imaging Clinic on Manhattan's Upper East Side Featuring Cutting-Edge Scanners from United Imaging, Opens its Doors

Focusing on every detail, the clinic combines advanced multi-modality technology with highly tailored patient care to bring a new standard of preventive and diagnostic screenings to the center ofNew York City. HOUSTON, Sept. 28, 2023 /PRNewswire/ -- United Imaging, a leading global manufacturer...

2023-09-29 00:00 2035

Origin Agritech Limited Partners with Strategic Investor Relations, LLC to Support its Corporate Communications and Investor Relations Efforts

BEIJING, Sept. 28, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced that it has retained Strategic Investor Relations, LLC. ("SIR"), a leading boutique investor relations firm. This collaborati...

2023-09-28 23:34 1756

SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

CHENGDU, China, Sept. 28, 2023 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a partnership with The Structural Genomics Consortium ("SGC"), a public-private partnership that supports the discovery of new medi...

2023-09-28 21:30 1478

ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study

SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titledMethod and System of Monitoring a Diabetes Treatment Plan("Predictive A1c") has been granted in Singapore and has rec...

2023-09-28 20:28 5164

Mabwell Announces First Patient Dosed in Phase Ib/II Trial of its Novel Nectin-4 Targeting ADC in Combination with PD-1 Inhibitor

SHANGHAI, Sept. 28, 2023 /PRNewswire/ -- Mabwell (688062.SH) , an innovative biopharmaceutical company with entire industry chain, announced the first patient was dosed in a phase Ib/II trial of its novel Nectin-4 targeting ADC (R&D code: 9MW2821) in combination with PD-1 inhibitor for the treatm...

2023-09-28 20:00 1346

ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023

SEATTLE, Sept. 28, 2023 /PRNewswire/ -- ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-drug conjugate (ADC) therapeutics for cancer, announced four upcoming poster presentations on its ADC platform and lead clinical assets, rinatabart sesutecan (...

2023-09-28 20:00 2168

Health In Tech Partners With Tall Tree Administrators to Extend Health Insurance Options for Small Businesses

The Collaboration Provides Self-Funded Clients Access to Tailored Health Plans and Ancillary Products STUART, Fla., Sept. 28, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is excited to ann...

2023-09-28 20:00 1270

IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

82.4% of patients without prior CAR-T achieving Complete Response (CR) or better SHANGHAI and NANJING, China and SAN JOSE, Calif., Sept. 28, 2023 /PRNewswire/ -- IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and ant...

2023-09-28 18:09 1472

AIA celebrates the grand opening of "AIA Alta Wellness Haven"

Hong Kong insurance industry's first one-stop wellness realm that integrates science andEast-meets-West philosophy Amplifies AIA's High Net Worth Proposition with the establishment of "AIA Club Alta" HONG KONG, Sept. 28, 2023 /PRNewswire/ -- Following the resounding success of the launch of "A...

2023-09-28 17:27 2760

PATIENTS SPEAK UP ABOUT KIDNEY DISEASE

COMMUNITY HEALTH CAMPAIGN "LIVE YOUR WAY" LAUNCHES ACROSS SINGAPORE * Life with kidney disease the focus of new public health campaign * Baxter Healthcare and National Kidney Foundation partner for patients SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Baxter International, a global medtech leade...

2023-09-28 13:48 1995

ScolioLife® Scoliosis & Spine Correction Clinic: A Beacon of Hope for Patients

~ ScolioLife® Pioneers a Comprehensive and Holistic Approach to Scoliosis Management ~ SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Dr Kevin Lau , renowned scoliosis specialist and founder of ScolioLife®, has introduced an innovative and holistic approach...

2023-09-28 12:04 1792

Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes

HONG KONG, Sept. 27, 2023 /PRNewswire/ --  Akeso, Inc. (the Company, Akeso, 9926.HK) announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for AK117, a next generation CD47 monoclonal antibody in combination with azaciti...

2023-09-28 10:07 1608

BIOHK2023 LEAVES A MARK ON BIOTECH COMMUNITY: MUST-KNOW HIGHLIGHTS

HONG KONG, Sept. 28, 2023 /PRNewswire/ -- The journey of BIOHK2023 began with an unforgettable opening ceremony on day one, welcoming theNobel Trust Foundation, Dr. Michael Nobel and delivering a noteworthy speech by Mr. Peter Nobel. BIOHK had the privilege of hosting distinguished doctors, profe...

2023-09-28 10:00 2404

BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China

WUXI, China, Sept. 27, 2023 /PRNewswire/ -- September 25th, 2023, BioCity Biopharma and AstraZeneca signed an agreement to  collaborate on a Phase Ib/II clinical study to evaluate the safety and efficacy of BioCity's BC3402, a monoclonal antibody (mAb) targeting the T cell immunoglobulin and muci...

2023-09-28 09:46 1937

Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting

SHANGHAI and HONG KONG, Sept. 28, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for canc...

2023-09-28 08:30 1922

Everest Medicines Announces Approval of XERAVA® in Taiwan for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients

SHANGHAI, Sept. 28, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the T...

2023-09-28 07:38 1980

Lunit to Reveal 6 Abstracts at the SITC 2023 Annual Meeting

- Lunit's 6 posters unveil new tumor microenvironment insights and the predictive power of Lunit SCOPE across diverse cancer types at SITC 2023 SEOUL, South Korea, Sept. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeu...

2023-09-27 22:03 1609

Emotional Link LLC CEO Naoto Sato Interviews Associate Professor Mai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS"

TOKYO, Sept. 27, 2023 /PRNewswire/ -- Emotional Link LLC , a business information dissemination company based inChuo Ward, Tokyo, has released an interview article with Associate ProfessorMai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS". ...

2023-09-27 22:00 2354

OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need.

SHANGHAI, Sept. 27, 2023 /PRNewswire/ -- In Shanghai, China, on August, OBiO Technology, a prominent leader in the Cell and Gene Therapy (CGT) field and a Contract Development and Manufacturing Organization, proudly unveiled the official launch of its state-of-the-art GMP production facility, chr...

2023-09-27 21:00 1536
1 ... 159160161162163164165 ... 847